Characterisation of an Atrx Conditional Knockout Mouse Model: Atrx Loss Causes Endocrine Dysfunction Rather Than Pancreatic Neuroendocrine Tumour
Authors:
- Tiago Bordeira GasparTiago Bordeira Gaspar
- Sofia MacedoSofia Macedo
- Ana SáASAna Sá
- Mariana Alves SoaresMSMariana Alves Soares
- Daniela Ferreira RodriguesDRDaniela Ferreira Rodrigues
- Mafalda SousaMSMafalda Sousa
- Nuno MendesNMNuno Mendes
- Rui Sousa MartinsRui Sousa Martins
- Luís CardosoLCLuís Cardoso
- Inês BorgesIBInês Borges
- Sule CanberkSule Canberk
- Fátima GärtnerFGFátima Gärtner
Open Access
Abstract
ATRX is a chromatin remodeller that maintains telomere homeostasis. Loss of ATRX is described in approximately 10% of pancreatic neuroendocrine tumours (PanNETs) and associated with poorer prognostic features. Here, we present a genetically engineered mouse model (GEMM) addressing the role of Atrx loss (AtrxKO) in pancreatic β cells, evaluating a large cohort of ageing mice (for up to 24 months (mo.)). Atrx loss did not cause PanNET formation but rather resulted in worsening of ageing-related pancreatic inflammation and endocrine dysfunction in the first year of life. Histopathological evaluation highlighted an exacerbated prevalence and intensity of pancreatic inflammation, ageing features, and hepatic steatosis in AtrxKO mice. Homozygous floxed mice presented hyperglycaemia, increased weights, and glucose intolerance after 6 months, but alterations in insulinaemia were not detected. Floxed individuals presented an improper growth of their pancreatic endocrine fraction that may explain such an endocrine imbalance. A pilot study of BRACO-19 administration to AtrxKO mice resulted in telomere instability, reinforcing the involvement of Atrx in the maintenance of β cell telomere homeostasis. Thereby, a non-obese dysglycaemic GEMM of disrupted Atrx is here presented as potentially useful for metabolic studies and putative candidate for inserting additional tumourigenic genetic events.Keywords
Funding Information
- Fundação para a Ciência e a Tecnologia (SFRH/BD/129431/2017, CEEC-IND/00201/2017)
- Norte Portugal Regional Operational Programme (NORTE 2020) (SFRH/BD/129431/2017, CEEC-IND/00201/2017)
This publication has 69 references indexed in Scilit:
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Altered Telomeres in Tumors with ATRX and DAXX MutationsScience, 2011
- Long interspersed nuclear element-1 hypomethylation in cancer: biology and clinical applicationsClinical Epigenetics, 2011
- DAXX / ATRX , MEN1 , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine TumorsScience, 2011
- Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in miceDisease Models & Mechanisms, 2010
- Distinct Factors Control Histone Variant H3.3 Localization at Specific Genomic RegionsCell, 2010
- No mantle formation in rodent islets—The prototype of islet revisitedDiabetes Research and Clinical Practice, 2009
- Stabilization of quadruplex DNA perturbs telomere replication leading to the activation of an ATR-dependent ATM signaling pathwayNucleic Acids Research, 2009
- Mutations in the chromatin-associated protein ATRXHuman Mutation, 2008
- High-throughput telomere length quantification by FISH and its application to human population studiesProceedings of the National Academy of Sciences, 2007